Bioanalytical
Biologically active substances associated with cancer studied using MS
Jul 13 2010
Ghent University, Belgium's oldest and largest public university, undertook the research in collaboration with Imperial College London and the US National Human Genome Research Institute.
MS was used to identify a chaperone molecule, HSP90-alpha, as one of the biologically active substances that promotes invasive growth in breast cancers.
The finding was part of scientists' efforts to prove that Rab27B, part of a family of guanosine triphosphate binding enzymes, promotes invasiveness of breast cancer tumours.
According to their discoveries, increased expression of Rab27B "is associated with poor prognosis in humans".
However, derailing the exocytosis - the release of vesicle content - associated with Rab27B can help to regulate invasive tumour growth and metastasis in some breast cancers.
The scientists conclude that "considerable therapeutic potential" lies in the future development of Rab27B as an avenue for cancer treatments.
Digital Edition
Chromatography Today - Buyers' Guide 2022
October 2023
In This Edition Modern & Practical Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...
View all digital editions
Events
Nov 12 2024 Tel Aviv, Israel
Nov 18 2024 Shanghai, China
Nov 18 2024 Plainsboro, NJ, USA
Nov 20 2024 Karachi, Pakistan
Jan 20 2025 Amsterdam, Netherlands